动脉样硬化是一种动脉样硬化
1Department of Medicine, Biology Institute, University of California, Los Angeles 90095, USA. jlusis@mednet.ucla.edu
Nature
|September 23, 2000
概括
动脉样硬化是心脏病和中风的主要原因,是一种复杂的炎症状况. 新的工具揭示了胆固醇代谢和风险因素如何促进动脉样硬化斑块的发展.
科学领域:
- 心血管科学 心血管科学
- 病理学 病理学 病理学
- 分子生物学分子生物学
背景情况:
- 动脉样硬化是全球主要的死亡原因,在西方化社会中约占所有死亡的50%.
- 这是一种复杂的疾病,有许多环境和遗传风险因素,使其细胞和分子机制难以定义.
- 历史上被视为衰老的退行过程,最近的研究将动脉样硬化重新定义为慢性炎症疾病.
研究的目的:
- 阐明动脉样硬化背后的分子机制.
- 了解改变胆固醇代谢,其他风险因素和动脉样硬化斑块形成之间的联系.
- 将动脉样硬化与衰老的简单后果区分开来,将其描述为一种炎症性疾病.
主要方法:
- 利用转基因小鼠模型研究疾病的发展.
- 应用新的调查工具来分析细胞和分子相互作用.
- 对风险因素的流行病学研究的综合发现.
主要成果:
- 确定了关键的分子机制,将胆固醇代谢和风险因素与动脉样硬化斑块联系起来.
- 证明动脉样硬化是一种慢性炎症状况,而不仅仅是退行性衰老过程.
- 确立了斑块破裂和血栓形成可以导致急性临床事件.
结论:
- 动脉样硬化是一种复杂的炎症性疾病,由相互关联的危险因素和代谢变化驱动.
- 先进的调查工具,特别是小鼠模型,显著改善了对动脉样硬化斑块发展的理解.
- 动脉样硬化需要从退行性观点转变为认识到其炎症性和潜在的急性性质.
相关概念视频
Inflammation
46.6K
Overview
46.6K
Atherosclerosis I: Introduction
2.5K
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
2.5K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
948
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
948
Atherosclerosis III: Management
741
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
741
Atherosclerosis IV: Nursing Management
611
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
611
Peripheral Artery Disease I: Introduction
659
Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
659


